DE69940684D1 - Verfahren zur Festkörperkristallisierung - Google Patents

Verfahren zur Festkörperkristallisierung

Info

Publication number: DE69940684D1
Authority: DE; Germany
Prior art keywords: solid; state crystallization; crystallization; state
Prior art date: 1998-02-25
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE69940684T

Other languages

English (en)

Inventor

Juan Angeles Uribe

Gyves Aurelio De

Abraham Gomez

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Skendi Finance Ltd Virgin Islands

Original Assignee

Skendi Finance Ltd Virgin Islands

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-02-25

Filing date

1999-02-10

Publication date

2009-05-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21853984&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69940684(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1999-02-10 Application filed by Skendi Finance Ltd Virgin Islands filed Critical Skendi Finance Ltd Virgin Islands

2009-05-14 Application granted granted Critical

2009-05-14 Publication of DE69940684D1 publication Critical patent/DE69940684D1/de

2019-02-11 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T428/00—Stock material or miscellaneous articles
- Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
- Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
- Y10T428/2989—Microcapsule with solid core [includes liposome]

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Processes Of Treating Macromolecular Substances (AREA)

DE69940684T 1998-02-25 1999-02-10 Verfahren zur Festkörperkristallisierung Expired - Lifetime DE69940684D1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US09/030,388 US6287693B1 (en)	1998-02-25	1998-02-25	Stable shaped particles of crystalline organic compounds

Publications (1)

Publication Number	Publication Date
DE69940684D1 true DE69940684D1 (de)	2009-05-14

Family

ID=21853984

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
DE69934099T Expired - Lifetime DE69934099T2 (de)	1998-02-25	1999-02-10	Stabile geformte teilchen kristalliner organischer verbindungen
DE69940684T Expired - Lifetime DE69940684D1 (de)	1998-02-25	1999-02-10	Verfahren zur Festkörperkristallisierung

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
DE69934099T Expired - Lifetime DE69934099T2 (de)	1998-02-25	1999-02-10	Stabile geformte teilchen kristalliner organischer verbindungen

Country Status (35)

Country	Link
US (7)	US6287693B1 (de)
EP (4)	EP1056444B1 (de)
JP (2)	JP4885357B2 (de)
KR (1)	KR100726315B1 (de)
CN (2)	CN1146407C (de)
AR (3)	AR018107A1 (de)
AT (2)	ATE345779T1 (de)
AU (1)	AU747779B2 (de)
BR (1)	BR9908156A (de)
CA (1)	CA2319176C (de)
CL (1)	CL2010001333A1 (de)
CY (1)	CY1118522T1 (de)
CZ (1)	CZ301042B6 (de)
DE (2)	DE69934099T2 (de)
DK (3)	DK1772141T3 (de)
EE (1)	EE05019B1 (de)
ES (3)	ES2609284T3 (de)
HK (2)	HK1036017A1 (de)
HU (1)	HUP0101271A3 (de)
ID (1)	ID26523A (de)
IL (2)	IL137970A0 (de)
MY (1)	MY138375A (de)
NO (1)	NO331804B1 (de)
NZ (1)	NZ505987A (de)
PE (1)	PE20000393A1 (de)
PL (1)	PL196369B1 (de)
PT (1)	PT2085075T (de)
RU (1)	RU2225708C2 (de)
SA (1)	SA99200098B1 (de)
TR (1)	TR200002462T2 (de)
TW (1)	TWI256308B (de)
UA (1)	UA73470C2 (de)
UY (1)	UY25404A1 (de)
WO (1)	WO1999043304A1 (de)
ZA (1)	ZA991058B (de)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6287693B1 (en)	1998-02-25	2001-09-11	John Claude Savoir	Stable shaped particles of crystalline organic compounds
US6667344B2 (en)	2001-04-17	2003-12-23	Dey, L.P.	Bronchodilating compositions and methods
EP2767539B1 (de)	2002-05-16	2017-07-12	Janssen Sciences Ireland UC	Pseudopolymorphe Formen eines HIV-Proteaseinhibitors
US20040028747A1 (en) *	2002-08-06	2004-02-12	Tucker Christopher J.	Crystalline drug particles prepared using a controlled precipitation process
US20040028746A1 (en) *	2002-08-06	2004-02-12	Sonke Svenson	Crystalline drug particles prepared using a controlled precipitation (recrystallization) process
AU2004246870B2 (en) *	2003-06-13	2009-07-23	Skendi Finance Ltd	Slow release estradiol-progesterone formulation for contraception and hormone replacement therapy
TWI359675B (en)	2003-07-10	2012-03-11	Dey L P	Bronchodilating β-agonist compositions
EP1646354A4 (de) *	2003-07-22	2010-03-17	Baxter Int	Kleine kugelförmige teilchen von niedermolekularen organischen molekülen und herstellungs- und anwendungsverfahren dafür
CA2547774A1 (en) *	2003-12-04	2005-06-16	Pfizer Products Inc.	Method for making pharmaceutical multiparticulates
DE602005013490D1 (de)	2004-02-23	2009-05-07	Euro Celtique Sa	Missbrauchsichere transdermale abgabevorrichtung für opioide, enthaltend opioidantagonist in form von mikrokügelchen
US20080200682A1 (en) *	2005-06-17	2008-08-21	Basf Aktiengesellschaft	Process of Producing Bleach Boosters
JP2011515495A (ja) *	2008-03-26	2011-05-19	オールトランツインコーポレイティド	オピエートアゴニスト及びアゴニスト−アンタゴニストの乱用抑制経皮製剤
CA2721509A1 (en) *	2008-04-14	2009-10-22	Posi Visionary Solutions Llp	Method and pharmaceutical composition for obtaining the plasmatic progesterone levels required for different therapeutic indications
FR2939326B1 (fr) *	2008-12-10	2011-04-01	Univ Joseph Fourier	Procede et dispositif de controle d'une cristallisation.
EP2477610A1 (de)	2009-09-17	2012-07-25	Upsher-Smith Laboratories, Inc.	Verzögert freigesetztes produkt mit einer kombination aus einem nichtopioiden amin und einem nichtsteroiden entzündungshemmenden mittel
UY33103A (es) *	2009-12-15	2011-07-29	Techsphere S A De C V	Formulacion farmaceutica parenteral en suspension, de liberacion sostenida, en dosis baja y ultra baja, en terapia hormonal en el sindrome climaterico
JP5692873B2 (ja) *	2010-03-19	2015-04-01	第一三共株式会社	ジアミン誘導体の結晶およびその製造方法
KR101314126B1 (ko)	2011-03-11	2013-10-04	서울대학교산학협력단	다면체 형상의 약물 전달 시스템
US9351924B2 (en)	2011-03-11	2016-05-31	Snu R&Db Foundation	Drug delivery system including laminated structure
HUE055562T2 (hu)	2011-11-23	2021-11-29	Therapeuticsmd Inc	Természetes kombinációjú hormon helyettesítõ kiszerelések, és terápiák ezekkel
US9301920B2 (en)	2012-06-18	2016-04-05	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US20150196640A1 (en)	2012-06-18	2015-07-16	Therapeuticsmd, Inc.	Progesterone formulations having a desirable pk profile
US10806740B2 (en)	2012-06-18	2020-10-20	Therapeuticsmd, Inc.	Natural combination hormone replacement formulations and therapies
US10806697B2 (en)	2012-12-21	2020-10-20	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US20130338122A1 (en)	2012-06-18	2013-12-19	Therapeuticsmd, Inc.	Transdermal hormone replacement therapies
US11246875B2 (en)	2012-12-21	2022-02-15	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10568891B2 (en)	2012-12-21	2020-02-25	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US11266661B2 (en)	2012-12-21	2022-03-08	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US9180091B2 (en)	2012-12-21	2015-11-10	Therapeuticsmd, Inc.	Soluble estradiol capsule for vaginal insertion
US10471072B2 (en)	2012-12-21	2019-11-12	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
US10537581B2 (en)	2012-12-21	2020-01-21	Therapeuticsmd, Inc.	Vaginal inserted estradiol pharmaceutical compositions and methods
EP3581576B1 (de)	2013-03-15	2022-01-26	Incyte Holdings Corporation	Trizyklische heterozyklen als bet-proteininhibitoren zur behandlung einer proliferativen erkrankung in kombination mit einem janus-kinaseinhibitor
US9309246B2 (en)	2013-12-19	2016-04-12	Incyte Corporation	Tricyclic heterocycles as BET protein inhibitors
CN106414442B (zh)	2014-04-23	2019-03-15	因赛特公司	作为BET蛋白抑制剂的1H-吡咯并[2,3-c]吡啶-7(6H)-酮和吡唑并[3,4-c]吡啶-7(6H)-酮
EP3145489A1 (de)	2014-05-22	2017-03-29	TherapeuticsMD, Inc.	Natürliche kombinierte hormonersatzformulierungen und therapien
US10328087B2 (en)	2015-07-23	2019-06-25	Therapeuticsmd, Inc.	Formulations for solubilizing hormones
ITUB20153652A1 (it)	2015-09-16	2017-03-16	Fatro Spa	Microsfere contenenti lattoni macrociclici antielminitici
BR112018070199A2 (pt)	2016-04-01	2019-01-29	Therapeuticsmd Inc	composição farmacêutica de hormônio esteroide
US10286077B2 (en)	2016-04-01	2019-05-14	Therapeuticsmd, Inc.	Steroid hormone compositions in medium chain oils
FI3472157T3 (fi)	2016-06-20	2023-06-01	Incyte Corp	Bet-inhibiittorin kiteisiä kiinteitä muotoja
PL236889B1 (pl) *	2017-10-03	2021-02-22	Univ Warszawski Medyczny	Nowa forma krystaliczna bezwodnego 17-β-estradiolu, sposób jej otrzymywania oraz kompozycja farmaceutyczna zawierająca nową formę krystaliczną bezwodnego 17-β-estradiolu i jej zastosowanie
EP3542786A1 (de) *	2018-03-21	2019-09-25	ITF Research Pharma, S.L.U.	Intravaginale progesteronvorrichtungen
US11633405B2 (en)	2020-02-07	2023-04-25	Therapeuticsmd, Inc.	Steroid hormone pharmaceutical formulations
US11833155B2 (en)	2020-06-03	2023-12-05	Incyte Corporation	Combination therapy for treatment of myeloproliferative neoplasms

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2447362A (en)	1945-11-01	1948-08-17	Rca Corp	Production of crystals
US3800038A (en) *	1972-04-21	1974-03-26	Biolog Concepts Inc	Uterine administraton of eutectic solid solutions of steroid hormones in a steroidal lipid carrier
US4230621A (en) *	1978-05-01	1980-10-28	E. R. Squibb & Sons, Inc.	Steroid derivatives and their use in radioimmunoassays
DE2843963A1 (de) *	1978-10-09	1980-04-24	Merck Patent Gmbh	Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin
IL63968A (en)	1980-10-01	1985-10-31	Glaxo Group Ltd	Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
JPS5799562A (en)	1980-12-12	1982-06-21	Nippon Shinyaku Co Ltd	Preparation of microcrystal
DE3049196A1 (de)	1980-12-24	1982-07-29	Bayer Ag, 5090 Leverkusen	Verfahren zur herstellung von granulaten aus organischen in form einer schmelze vorliegenden stoffen
US4447426A (en) *	1982-01-18	1984-05-08	E. R. Squibb & Sons, Inc.	Steroid monohydrates, formulations containing same and method
JPS58143832A (ja)	1982-02-22	1983-08-26	Yoshiaki Kawashima	結晶性化学物質の球状化再結晶法
DE3213025C2 (de)	1982-04-02	1997-06-12	Fischer Karl Ind Gmbh	Verfahren zur Nachkondensation von Polykondensaten
GB8618847D0 (en) *	1986-08-01	1986-09-10	Smith Kline French Lab	Pharmaceutical formulations
JPH0714625B2 (ja)	1987-03-30	1995-02-22	呉羽化学工業株式会社	高結晶化ポリアリ−レンチオエ−テル成形物
US4897307A (en)	1987-08-11	1990-01-30	The Dow Chemical Company	Process for the solvent-induced crystallization of amorphous poly(etheretherketone)-type polymers and the article formed thereby
WO1989002904A1 (en)	1987-09-28	1989-04-06	Asahi Kasei Kogyo Kabushiki Kaisha	Process for preparing crystallized aromatic polycarbonate and crystallized aromatic polycarbonate obtained by the process
US4919899A (en)	1988-02-29	1990-04-24	Herrmann Frederick T	Crystal growth apparatus
YU120988A (en) *	1988-06-23	1990-06-30	Lek Tovarna Farmacevtskih	Process for preparing new dispersion pills of cimetidine
IT1230566B (it) *	1988-10-17	1991-10-28	Vectorpharma Int	Farmaci poco solubili supportati su sostanze polimeriche in forma atta all'aumento della velocita' di dissoluzione
US5360478A (en)	1989-10-16	1994-11-01	Phasex Corporation	Gas anti-solvent recrystallization process
FR2663223B1 (fr)	1990-06-14	1994-12-02	Af Aplicaciones Far Lab	Forme galenique parenterale.
FR2663224B1 (fr) *	1990-06-14	1995-01-20	Applicationes Farmaceuticas Sa	Forme galenique parenterale.
JPH04305226A (ja)	1991-01-25	1992-10-28	Senichi Masuda	ガス中窒素酸化物の低減方法
US5874063A (en) *	1991-04-11	1999-02-23	Astra Aktiebolag	Pharmaceutical formulation
SE9101090D0 (sv)	1991-04-11	1991-04-11	Astra Ab	Process for conditioning of water-soluble substances
SE9302777D0 (sv) *	1993-08-27	1993-08-27	Astra Ab	Process for conditioning substances
US5391810A (en)	1991-05-23	1995-02-21	Ajinomoto Co., Inc.	Method of crystallizing α-L-aspartyl-L-phenylalanine methyl ester
DE4130173A1 (de)	1991-09-11	1993-03-18	Bayer Ag	Pharmazeutische zubereitungen mit einer speziellen kristallmodifikation des 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridindicarbonsaeure-isopropyl-(2-methoxyethyl)-esters
DE4218929C1 (de)	1992-06-10	1993-09-09	Deutsche Bundesbahn, Vertreten Durch Das Bundesbahn-Zentralamt Minden (Westf.), 4950 Minden, De
US5290913A (en)	1992-10-08	1994-03-01	Carrier Vibrating Equipment, Inc.	Method and apparatus for the heat treatment of material
US5558678A (en)	1992-11-13	1996-09-24	Karl Fischer Industrieanlagen Gmbh	Process and apparatus for continuous crystallization of plastic granules
US5686092A (en)	1992-11-24	1997-11-11	Alkermes Controlled Therapeutics Inc. Ii	Growth promoters for animals
WO1994020116A1 (en) *	1993-03-10	1994-09-15	University Of Alabama Research Foundation	Artificial primers for glycogen synthesis
US5409605A (en) *	1993-08-05	1995-04-25	Chemical Lime Company	Apparatus and method for treating waste sludge
JPH0757558A (ja) *	1993-08-09	1995-03-03	Showa Electric Wire & Cable Co Ltd	耐熱絶縁電線
DE4440337A1 (de) *	1994-11-11	1996-05-15	Dds Drug Delivery Services Ges	Pharmazeutische Nanosuspensionen zur Arzneistoffapplikation als Systeme mit erhöhter Sättigungslöslichkeit und Lösungsgeschwindigkeit
US5849651A (en) *	1995-06-01	1998-12-15	Kabushiki Kaisha Toshiba	Reversible thermal recording medium
JPH0957558A (ja) *	1995-08-18	1997-03-04	Nabeya Iron & Tool Works Ltd	スライド装置
JPH09227558A (ja) *	1996-02-28	1997-09-02	Fujisawa Pharmaceut Co Ltd	チアゾール化合物の安定な結晶およびその製造方法
US6287693B1 (en) *	1998-02-25	2001-09-11	John Claude Savoir	Stable shaped particles of crystalline organic compounds
JP2000143832A (ja)	1998-11-10	2000-05-26	Toppan Printing Co Ltd	高剛性を有するフィルムまたはシート

1998
- 1998-02-25 US US09/030,388 patent/US6287693B1/en not_active Expired - Lifetime
1999
- 1999-02-10 RU RU2000124327/15A patent/RU2225708C2/ru not_active IP Right Cessation
- 1999-02-10 IL IL13797099A patent/IL137970A0/xx active IP Right Grant
- 1999-02-10 PT PT91562686T patent/PT2085075T/pt unknown
- 1999-02-10 EP EP99902729A patent/EP1056444B1/de not_active Expired - Lifetime
- 1999-02-10 AT AT99902729T patent/ATE345779T1/de active
- 1999-02-10 BR BR9908156-3A patent/BR9908156A/pt not_active Application Discontinuation
- 1999-02-10 EP EP10183811A patent/EP2319497B1/de not_active Expired - Lifetime
- 1999-02-10 DE DE69934099T patent/DE69934099T2/de not_active Expired - Lifetime
- 1999-02-10 ZA ZA9901058A patent/ZA991058B/xx unknown
- 1999-02-10 EE EEP200000492A patent/EE05019B1/xx unknown
- 1999-02-10 CN CNB998032794A patent/CN1146407C/zh not_active Expired - Fee Related
- 1999-02-10 ES ES09156268.6T patent/ES2609284T3/es not_active Expired - Lifetime
- 1999-02-10 ID IDW20001723A patent/ID26523A/id unknown
- 1999-02-10 JP JP2000533103A patent/JP4885357B2/ja not_active Expired - Fee Related
- 1999-02-10 AU AU22936/99A patent/AU747779B2/en not_active Expired
- 1999-02-10 AT AT06022834T patent/ATE427102T1/de active
- 1999-02-10 PL PL343170A patent/PL196369B1/pl unknown
- 1999-02-10 DE DE69940684T patent/DE69940684D1/de not_active Expired - Lifetime
- 1999-02-10 EP EP09156268.6A patent/EP2085075B1/de not_active Expired - Lifetime
- 1999-02-10 CZ CZ20003047A patent/CZ301042B6/cs not_active IP Right Cessation
- 1999-02-10 ES ES99902729T patent/ES2275334T3/es not_active Expired - Lifetime
- 1999-02-10 KR KR1020007009352A patent/KR100726315B1/ko not_active IP Right Cessation
- 1999-02-10 WO PCT/IB1999/000233 patent/WO1999043304A1/en active IP Right Grant
- 1999-02-10 NZ NZ505987A patent/NZ505987A/en not_active IP Right Cessation
- 1999-02-10 EP EP06022834A patent/EP1772141B1/de not_active Expired - Lifetime
- 1999-02-10 HU HU0101271A patent/HUP0101271A3/hu unknown
- 1999-02-10 DK DK06022834T patent/DK1772141T3/da active
- 1999-02-10 CN CNB2004100076469A patent/CN100528140C/zh not_active Expired - Fee Related
- 1999-02-10 DK DK99902729T patent/DK1056444T3/da active
- 1999-02-10 TR TR2000/02462T patent/TR200002462T2/xx unknown
- 1999-02-10 ES ES06022834T patent/ES2324366T3/es not_active Expired - Lifetime
- 1999-02-10 CA CA002319176A patent/CA2319176C/en not_active Expired - Fee Related
- 1999-02-10 DK DK09156268.6T patent/DK2085075T3/en active
- 1999-02-12 MY MYPI99000491A patent/MY138375A/en unknown
- 1999-02-17 PE PE1999000141A patent/PE20000393A1/es not_active IP Right Cessation
- 1999-02-23 AR ARP990100728A patent/AR018107A1/es not_active Application Discontinuation
- 1999-02-24 UY UY25404A patent/UY25404A1/es not_active Application Discontinuation
- 1999-03-12 TW TW088103853A patent/TWI256308B/zh not_active IP Right Cessation
- 1999-05-05 SA SA99200098A patent/SA99200098B1/ar unknown
- 1999-10-02 UA UA2000095446A patent/UA73470C2/uk unknown
2000
- 2000-07-12 US US09/615,061 patent/US6537580B1/en not_active Expired - Lifetime
- 2000-08-20 IL IL137970A patent/IL137970A/en not_active IP Right Cessation
- 2000-08-24 NO NO20004241A patent/NO331804B1/no not_active IP Right Cessation
2001
- 2001-05-23 US US09/862,723 patent/US6528094B1/en not_active Expired - Lifetime
- 2001-10-04 HK HK01106985A patent/HK1036017A1/xx not_active IP Right Cessation
2002
- 2002-01-15 US US10/045,148 patent/US6638536B2/en not_active Expired - Lifetime
- 2002-05-29 US US10/156,079 patent/US6663895B2/en not_active Expired - Lifetime
2003
- 2003-02-26 US US10/373,088 patent/US6737081B2/en not_active Expired - Lifetime
- 2003-02-26 US US10/372,897 patent/US7427413B2/en not_active Expired - Fee Related
2010
- 2010-03-17 AR ARP100100844A patent/AR077167A2/es not_active Application Discontinuation
- 2010-03-17 AR ARP100100845A patent/AR077168A2/es not_active Application Discontinuation
- 2010-12-02 CL CL2010001333A patent/CL2010001333A1/es unknown
2011
- 2011-07-22 JP JP2011161017A patent/JP2011241220A/ja not_active Withdrawn
- 2011-09-14 HK HK11109693.8A patent/HK1155384A1/xx not_active IP Right Cessation
2016
- 2016-12-28 CY CY20161101356T patent/CY1118522T1/el unknown

Also Published As

Publication number	Publication date
EP2319497B1 (de)	2012-08-22
ES2275334T3 (es)	2007-06-01
NZ505987A (en)	2003-07-25
NO20004241L (no)	2000-08-24
DK1056444T3 (da)	2007-03-12
UA73470C2 (uk)	2005-08-15
EP2085075B1 (de)	2016-09-28
EP2085075A1 (de)	2009-08-05
TR200002462T2 (tr)	2000-11-21
SA99200098B1 (ar)	2006-04-26
ZA991058B (en)	1999-08-11
WO1999043304A1 (en)	1999-09-02
US6638536B2 (en)	2003-10-28
PE20000393A1 (es)	2000-05-04
NO331804B1 (no)	2012-04-10
DE69934099D1 (de)	2007-01-04
EP1772141A1 (de)	2007-04-11
UY25404A1 (es)	1999-05-14
EP1772141B1 (de)	2009-04-01
EE200000492A (et)	2002-02-15
KR20010034540A (ko)	2001-04-25
US6287693B1 (en)	2001-09-11
TWI256308B (en)	2006-06-11
ATE427102T1 (de)	2009-04-15
EE05019B1 (et)	2008-06-16
CN1291887A (zh)	2001-04-18
EP2319497A1 (de)	2011-05-11
US6528094B1 (en)	2003-03-04
HUP0101271A3 (en)	2002-10-28
US20030191101A1 (en)	2003-10-09
US20040166164A1 (en)	2004-08-26
ATE345779T1 (de)	2006-12-15
HK1036017A1 (en)	2001-12-21
JP4885357B2 (ja)	2012-02-29
CN100528140C (zh)	2009-08-19
AU2293699A (en)	1999-09-15
CN1146407C (zh)	2004-04-21
NO20004241D0 (no)	2000-08-24
AR077167A2 (es)	2011-08-10
HK1155384A1 (en)	2012-05-18
JP2002504507A (ja)	2002-02-12
IL137970A (en)	2006-10-05
HUP0101271A2 (hu)	2001-09-28
EP1056444B1 (de)	2006-11-22
US7427413B2 (en)	2008-09-23
PL343170A1 (en)	2001-07-30
CN1524608A (zh)	2004-09-01
MY138375A (en)	2009-05-29
ES2609284T3 (es)	2017-04-19
DK1772141T3 (da)	2009-07-20
KR100726315B1 (ko)	2007-06-11
ES2324366T3 (es)	2009-08-05
AR077168A2 (es)	2011-08-10
JP2011241220A (ja)	2011-12-01
CY1118522T1 (el)	2017-07-12
ID26523A (id)	2001-01-11
DE69934099T2 (de)	2007-06-21
US20020168395A1 (en)	2002-11-14
US20030147964A1 (en)	2003-08-07
IL137970A0 (en)	2001-10-31
RU2225708C2 (ru)	2004-03-20
PT2085075T (pt)	2017-01-04
AR018107A1 (es)	2001-10-31
AU747779B2 (en)	2002-05-23
CA2319176C (en)	2007-09-11
CA2319176A1 (en)	1999-09-02
PL196369B1 (pl)	2007-12-31
US6737081B2 (en)	2004-05-18
EP1056444A1 (de)	2000-12-06
US6537580B1 (en)	2003-03-25
CL2010001333A1 (es)	2011-04-25
US6663895B2 (en)	2003-12-16
DK2085075T3 (en)	2017-01-23
BR9908156A (pt)	2000-10-31
CZ301042B6 (cs)	2009-10-21
CZ20003047A3 (cs)	2000-11-15

Legal Events

Date	Code	Title	Description
2010-04-22	8364	No opposition during term of opposition

Publication	Publication Date	Title
DE69940684D1 (de)	2009-05-14	Verfahren zur Festkörperkristallisierung
DE69921593D1 (de)	2004-12-09	Verfahren zur Kälteversorgung
DE60037724D1 (de)	2008-02-21	Verfahren zur chlor-herstellung
ATE247627T1 (de)	2003-09-15	Verfahren zur herstellung nicht-hygroscopische l (-) - carnitine salze
DE60134514D1 (de)	2008-08-07	Verfahren zur herstellung von l-arabinose
DE50002724D1 (de)	2003-08-07	Verfahren zur querstromfiltration
DE69916400D1 (de)	2004-05-19	Verfahren zur selektiven Entfernung von Nitrilen
DE60029182D1 (de)	2006-08-17	Verfahren zur eindeutigen Abstandsschätzung
DE50009496D1 (de)	2005-03-17	Verfahren zur gefriertrocknung
DE60014506D1 (de)	2004-11-11	Verfahren zur Entfernung von Organohalogenverbindungen
DE50114485D1 (de)	2008-12-24	Verfahren zur sichtweitenbestimmung
DE69940761D1 (de)	2009-06-04	Verfahren zur Transistorsherstellung
DE60041503D1 (de)	2009-03-19	Verfahren zur konturkorrektur
DE59912554D1 (de)	2005-10-20	Verfahren zur thermischen N2O-Zersetzung
DE69709695T8 (de)	2006-03-16	Verfahren zur seitenzusammensetzung
DE69939775D1 (de)	2008-12-04	Verfahren zur bildung zweifacher feldoxid-strukturen
DE59913007D1 (de)	2006-03-30	Verfahren zur Drehmomenteinstellung
DE50000893D1 (de)	2003-01-16	Verfahren zur veredelung
DE60030519D1 (de)	2006-10-19	Verfahren zur Unterdrückung von Phantombildern
DE69932857D1 (de)	2006-09-28	Verfahren zur reinigung von phosphorsäure
DE19983354T1 (de)	2001-08-16	Verfahren zur Hydroformylierung
DE60010753D1 (de)	2004-06-17	Verfahren zur reinigung von lactamen
ATE206392T1 (de)	2001-10-15	Verfahren zur alkylierug von gehinderten sulfonamiden
DE50001116D1 (de)	2003-02-20	Verfahren zur justage von parabolantennen
DE59900684D1 (de)	2002-02-21	Verfahren zur video-mikroskopie